JIMSMENews

Follow us : Mail

Shree Ganesh Remedies to migrate to BSE main board


The Board of Directors at Shree Ganesh Remedies considered and approved the migration of the company listing to the main board of BSE.

Company : Shree Ganesh Remedies Ltd

Board of Directors at Shree Ganesh Remedies considered and approved the migration of the company listing from BSE SME platform to the main board of Bombay Stock Exchange.

In August, 2017, Shree Ganesh Remedies issued 23.76 lacs equity shares at the value of Rs.36 per equity share, (face value of Rs. 10 each and premium of Rs. 26 per equity share) aggregating to Rs. 855.36 lacs.

The IPO opened on September 28, 2017, and closed on October 05, 2017.

Shree Ganesh Remedies is the pharmaceutical group engaged in the research, development, manufacture and marketing of healthcare products (Drug Intermediates & Pharmaceuticals) in 1991.


Recent Stories

Weekly Journal

Get weekly updates on latest SME news in your e-mail.


Weekly Journal
Get weekly updates on latest SME news in your e-mail.
Terms of Use |Privacy Policy
Copyright © 2019 JimSMEnews. The JimSMEnews is not responsible for the content of external sites. Read about our approach to external linking.